Hyperlysinemia type II results when mutations in the AASS gene affect only the C-terminal saccharopine dehydrogenase activity
This peptide was originally developed by Professor Frank Ng at Monash University in Australia during the 1990s as a potential anti-obesity treatment
Unlike tech, where monopolistic behavior is now regularly checked, Big Pharma still enjoys extraordinary protectionseven when the consequences are life-or-death
We work with compliant state-licensed 503A compounding pharmacies operating in accordance with applicable federal and state regulations
Albiglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Studies have examined GHK-Cu with the strength of 100mg for its effects on the production of collagen I and III, elastin, and glycosaminoglycans (GAGs), which are associated with skin elasticity, firmness, and density